Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Screening and Diagnosis of Nodules ≤2 cm in High-risk HCC Patients in China Based on US and CEUS: a Multicenter, Prospective, Randomized Controlled Study

NCT05360420 is registered in ClinicalTrials.gov with Tianjin Third Central Hospital as lead sponsor.

NCT NCT05360420
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05360420 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Screening and Diagnosis of Nodules ≤2 cm in High-risk HCC Patients in China Based on US and CEUS: a Multicenter, Prospective, Randomized Controlled Study
Lead sponsor
Tianjin Third Central Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
October 26, 2022
Completion date
December 31, 2024
Enrollment
6,730 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liver cancer, liver cirrhosis